We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $748M
1-Year Est. Return 27.21%
This Fund
S&P 500
This Quarter Est. Return
+13.8%
1 Year Est. Return
+27.21%
3 Year Est. Return
+69.53%
5 Year Est. Return
+110.76%
10 Year Est. Return
AUM
$705M
AUM Growth
+$74.9M
Cap. Flow
-$3.6M
Cap. Flow %
-0.51%
Top 10 Hldgs %
36.23%
Holding
79
New
3
Increased
37
Reduced
34
Closed
2

Top Buys

Rank Stock Value
1
KLAC icon
KLA
KLAC
+$1.49M
2
TGT icon
Target
TGT
+$836K
3
GNTX icon
Gentex
GNTX
+$696K
4
PKG icon
Packaging Corp of America
PKG
+$586K
5
AMGN icon
Amgen
AMGN
+$582K

Top Sells

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$2.1M
2
MSFT icon
Microsoft
MSFT
+$1.82M
3
AAPL icon
Apple
AAPL
+$1.5M
4
CBRL icon
Cracker Barrel
CBRL
+$1.33M
5
LEA icon
Lear
LEA
+$1.28M

Sector Composition

Rank Sector Weight
1 Technology 23.16%
2 Industrials 17.89%
3 Financials 15.76%
4 Consumer Discretionary 14.54%
5 Healthcare 14.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.67T
$39.6M 5.61%
222,801
-9,480
-4% -$1.5M
MSFT icon
2
Microsoft
MSFT
$3.71T
$28.4M 4.03%
84,451
-5,616
-6% -$1.82M
ACN icon
3
Accenture
ACN
$114B
$26.8M 3.81%
64,767
-1,461
-2% -$532K
MA icon
4
Mastercard
MA
$507B
$26.6M 3.78%
74,151
-60
-0.1% -$20.8K
MKC icon
5
McCormick & Company Non-Voting
MKC
$14B
$25.4M 3.61%
263,092
+2,682
+1% +$228K
CPRT icon
6
Copart
CPRT
$31.2B
$23.6M 3.35%
623,476
-15,924
-2% -$591K
AON icon
7
Aon
AON
$68.5B
$23.2M 3.29%
77,132
-103
-0.1% -$30.9K
APH icon
8
Amphenol
APH
$204B
$20.9M 2.96%
953,972
-5,100
-0.5% -$103K
GGG icon
9
Graco
GGG
$12.6B
$20.5M 2.91%
254,811
-1,231
-0.5% -$93.5K
UNH icon
10
UnitedHealth
UNH
$356B
$20.3M 2.88%
40,374
+1,045
+3% +$473K
ORCL icon
11
Oracle
ORCL
$457B
$18.5M 2.63%
212,570
+605
+0.3% +$56.8K
TTC icon
12
Toro Company
TTC
$8.83B
$18.2M 2.58%
182,107
+1,100
+0.6% +$110K
SEIC icon
13
SEI Investments
SEIC
$13.2B
$17.7M 2.51%
290,218
+3,498
+1% +$217K
PEP icon
14
PepsiCo
PEP
$188B
$17.6M 2.5%
101,578
-127
-0.1% -$20.7K
NVO
15
Novo Nordisk
NVO
$206B
$17.6M 2.5%
314,982
-1,584
-0.5% -$85.8K
TJX icon
16
TJX Companies
TJX
$145B
$17.6M 2.49%
231,584
+3,213
+1% +$223K
NKE icon
17
Nike
NKE
$57B
$17.4M 2.47%
104,244
-1,550
-1% -$256K
AMGN icon
18
Amgen
AMGN
$236B
$16.3M 2.32%
72,641
+2,756
+4% +$582K
EXPD icon
19
Expeditors International
EXPD
$24.5B
$15.2M 2.16%
113,428
+852
+0.8% +$107K
MRSH
20
Marsh
MRSH
$88.6B
$14.6M 2.07%
83,962
-756
-0.9% -$126K
ROL icon
21
Rollins
ROL
$17.3B
$14.3M 2.02%
416,860
-1,120
-0.3% -$39.2K
DLTR icon
22
Dollar Tree
DLTR
$24.7B
$13.9M 1.98%
65,407
+3,972
+6% +$482K
DEO icon
23
Diageo
DEO
$49.6B
$13.9M 1.97%
63,030
+279
+0.4% +$57.2K
ROST icon
24
Ross Stores
ROST
$73.7B
$13.3M 1.88%
116,014
+4,842
+4% +$541K
ORLY icon
25
O'Reilly Automotive
ORLY
$71.1B
$12.8M 1.82%
272,535
-2,070
-0.8% -$89.6K

Similar funds

JLB & Associates's Q4 2021 Portfolio in Review

As of Q4 2021, JLB & Associates held 79 positions worth $705M, up 12% from $630M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

JLB & Associates's Q4 2021 filing shows 3 new, 37 increased, 34 reduced and 2 closed positions. Its largest new stake was American Express: 1,704 shares worth $278K. The largest sale was Global Payments, an estimated $2.1M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Financials.

  • JLB & Associates's largest Q4 2021 buy was American Express: 1,704 shares worth $278K.
  • JLB & Associates added most to KLA in Q4 2021, an estimated $1.49M increase.
  • JLB & Associates's biggest Q4 2021 reduction was Global Payments, cutting an estimated $2.1M.
  • JLB & Associates fully exited Globe Life in Q4 2021, selling an estimated $400K.
  • JLB & Associates's ten largest holdings make up 36% of its $705M portfolio in Q4 2021.
  • JLB & Associates opened 3 new positions and closed 2 in Q4 2021.
  • JLB & Associates's portfolio value rose 12% quarter-over-quarter to $705M.

Based on JLB & Associates's 13F filing for Q4 2021, filed 26 Jan 2022.